Saad Mark E

Saad Mark E is listed in filings as Director at Axsome Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 10, 2026, including 2 public disclosures. Recent filings connect the profile to Axsome Therapeutics, Inc. (AXSM). The current snapshot covers public activity from Jun 9, 2026 to Jun 10, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.